VEEVA SYSTEMS INC CLASS A

NYSE: VEEV (Veeva Systems Inc.)

Last update: 20 Sep, 12:27AM

277.79

-1.29 (-0.46%)

Previous Close 279.08
Open 279.73
Volume 947,535
Avg. Volume (3M) 1,299,173
Market Cap 45,743,448,064
Price / Earnings (TTM) 57.16
Price / Earnings (Forward) 35.34
Price / Sales 16.94
Price / Book 7.45
52 Weeks Range
200.30 (-27%) — 296.72 (6%)
Earnings Date 27 Aug 2025
Profit Margin 27.34%
Operating Margin (TTM) 30.79%
Diluted EPS (TTM) 4.70
Quarterly Revenue Growth (YOY) 16.70%
Quarterly Earnings Growth (YOY) 41.20%
Total Debt/Equity (MRQ) 1.24%
Current Ratio (MRQ) 4.61
Operating Cash Flow (TTM) 1.20 B
Levered Free Cash Flow (TTM) 1.05 B
Return on Assets (TTM) 6.90%
Return on Equity (TTM) 14.06%

Market Trend

Short Term Medium Term
Industry Health Information Services (US) Bullish Mixed
Health Information Services (Global) Bullish Mixed
Stock Veeva Systems Inc. Bullish Bullish

AIStockmoo Score

0.2
Analyst Consensus 1.5
Insider Activity -3.5
Price Volatility -3.5
Technical Moving Averages 2.5
Technical Oscillators 4.0
Average 0.20

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
VEEV 46 B - 57.16 7.45
DOCS 14 B - 62.62 13.15
PHR 1 B - - 4.59
EVH 1 B - - 1.02
WEAV 505 M - - 6.40
TDOC 1 B - - 1.05

Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company’s best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.

Sector Healthcare
Industry Health Information Services
Investment Style Mid Growth
% Held by Insiders 8.55%
% Held by Institutions 86.32%
52 Weeks Range
200.30 (-27%) — 296.72 (6%)
Price Target Range
222.00 (-20%) — 380.00 (36%)
High 380.00 (TD Cowen, 36.79%) Buy
Median 325.00 (17.00%)
Low 222.00 (Morgan Stanley, -20.08%) Sell
Average 322.89 (16.24%)
Total 13 Buy, 4 Hold, 1 Sell
Avg. Price @ Call 275.17
Firm Date Target Price Call Price @ Call
TD Cowen 07 Oct 2025 380.00 (36.79%) Buy 306.22
JP Morgan 08 Sep 2025 330.00 (18.79%) Buy 282.78
28 Aug 2025 290.00 (4.40%) Hold 272.33
Mizuho 29 Aug 2025 325.00 (16.99%) Buy 269.20
BTIG 28 Aug 2025 340.00 (22.39%) Buy 272.33
Barclays 28 Aug 2025 325.00 (16.99%) Buy 272.33
Canaccord Genuity 28 Aug 2025 300.00 (8.00%) Hold 272.33
Citigroup 28 Aug 2025 349.00 (25.63%) Buy 272.33
Evercore ISI Group 28 Aug 2025 295.00 (6.20%) Hold 272.33
Morgan Stanley 28 Aug 2025 222.00 (-20.08%) Sell 272.33
Needham 28 Aug 2025 355.00 (27.79%) Buy 272.33
Oppenheimer 28 Aug 2025 325.00 (16.99%) Buy 272.33
Piper Sandler 28 Aug 2025 355.00 (27.79%) Buy 272.33
Raymond James 28 Aug 2025 340.00 (22.39%) Buy 272.33
Stifel 28 Aug 2025 320.00 (15.19%) Buy 272.33
Truist Securities 28 Aug 2025 275.00 (-1.00%) Hold 272.33
UBS 28 Aug 2025 310.00 (11.60%) Hold 272.33
Wells Fargo 28 Aug 2025 341.00 (22.75%) Buy 272.33
26 Aug 2025 326.00 (17.35%) Buy 286.54
Keybanc 14 Jul 2025 325.00 (16.99%) Buy 282.28
Show more
Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
DIAMOND KRISTINE - 293.26 -79 -23,168
FADDIS JONATHAN - 298.39 -20,856 -6,263,317
SCHWENGER THOMAS D. - 297.03 -4,244 -1,269,821
VAN WAGENER BRIAN - 293.26 -274 -80,353
ZUPPAS ELENI NITSA - 293.26 -761 -223,171
Aggregate Net Quantity -26,214
Aggregate Net Value ($) -7,859,830
Aggregate Avg. Buy ($) -
Aggregate Avg. Sell ($) 296.38
Name Holder Date Type Quantity Price Value ($)
FADDIS JONATHAN Officer 06 Oct 2025 Automatic sell (-) 720 299.76 215,827
FADDIS JONATHAN Officer 06 Oct 2025 Disposed (-) 5,001 299.76 1,499,100
FADDIS JONATHAN Officer 02 Oct 2025 Automatic sell (-) 14,595 300.79 4,390,030
FADDIS JONATHAN Officer 02 Oct 2025 Option execute 14,595 - -
SCHWENGER THOMAS D. Officer 02 Oct 2025 Automatic sell (-) 3,350 300.79 1,007,647
FADDIS JONATHAN Officer 01 Oct 2025 Disposed (-) 540 293.26 158,360
FADDIS JONATHAN Officer 01 Oct 2025 Option execute 1,226 - -
SCHWENGER THOMAS D. Officer 01 Oct 2025 Disposed (-) 894 293.26 262,174
SCHWENGER THOMAS D. Officer 01 Oct 2025 Option execute 2,043 - -
ZUPPAS ELENI NITSA Officer 01 Oct 2025 Disposed (-) 761 293.26 223,171
ZUPPAS ELENI NITSA Officer 01 Oct 2025 Option execute 1,498 - -
VAN WAGENER BRIAN Officer 01 Oct 2025 Disposed (-) 274 293.26 80,353
VAN WAGENER BRIAN Officer 01 Oct 2025 Option execute 872 - -
DIAMOND KRISTINE Officer 01 Oct 2025 Disposed (-) 79 293.26 23,168
DIAMOND KRISTINE Officer 01 Oct 2025 Option execute 218 - -
Show more
Date Type Details
29 Sep 2025 Announcement Industry Research Finds Two-Thirds of Clinical Data Managers and CRAs Believe Current Inefficiencies Put Data Quality at Future Risk
25 Sep 2025 Announcement Veeva to Host Virtual Investor Day on October 16, 2025
22 Sep 2025 Announcement Bristol Myers Squibb Commits to Veeva Vault CRM
10 Sep 2025 Announcement Gilead Sciences Commits to Veeva Vault CRM
02 Sep 2025 Announcement More Than 450 Companies Drive Speed to Market with Veeva RIM
02 Sep 2025 Announcement Veeva to Present at Upcoming Investor Conference
28 Aug 2025 Announcement Veeva Announces Collaboration with Global Biotech to Further Accelerate Clinical Trial Innovation
27 Aug 2025 Announcement Veeva Announces Fiscal 2026 Second Quarter Results
21 Aug 2025 Announcement Leaders Come Together to Advance the Industry at Veeva Summit
18 Aug 2025 Announcement IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes
18 Aug 2025 Announcement IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes
12 Aug 2025 Announcement Research Shows Medtechs Prioritizing Site Collaboration and Data Quality
06 Aug 2025 Announcement Veeva to Release Fiscal 2026 Second Quarter Results on August 27, 2025
30 Jul 2025 Announcement Survey Finds Medtechs Lack Confidence in Regulatory Data Quality
23 Jul 2025 Announcement Veeva OpenData and Veeva Network Enable Coordinated Customer Engagement for Boehringer Ingelheim
21 Jul 2025 Announcement Merck Commits to Veeva Vault CRM
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria